Search IconSearch

Tag: overweight

illustration showing action of a GLP-1 receptor agonist

Semaglutide Shows Secondary Cardiovascular Prevention Benefits in Patients Without Diabetes

Findings establish overweight/obesity as a modifiable risk factor for cardiovascular disease

November 2, 2016/Diabetes & Endocrinology

Whole-Grain Diet Selectively Lowers Diastolic BP in Overweight Adults Under 50

Study raises prospect of a nutritional adjunct for curbing CV risk

BackPage 1 of 1Next


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy